Understanding colorectal cancer differences in African Americans
Aggressive colorectal cancer subtypes and social disadvantage in a racially diverse cohort
['FUNDING_R01'] · GEORGETOWN UNIVERSITY · NIH-11212222
This study is looking into why African Americans have higher rates of colorectal cancer compared to non-Hispanic Whites, focusing on the genetic and social reasons behind this difference, so we can find better ways to screen and treat this group.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | GEORGETOWN UNIVERSITY (nih funded) |
| Locations | 1 site (WASHINGTON, UNITED STATES) |
| Trial ID | NIH-11212222 on ClinicalTrials.gov |
What this research studies
This research investigates the reasons behind higher rates of colorectal cancer (CRC) in African Americans compared to non-Hispanic Whites. It focuses on identifying specific genetic and social factors that contribute to these disparities, including tumor biology and socioeconomic conditions. By analyzing a diverse cohort of African American patients, the study aims to uncover how these factors influence CRC outcomes and survival rates. The findings could lead to improved screening and treatment strategies tailored for this population.
Who could benefit from this research
Good fit: Ideal candidates for this research are African American individuals diagnosed with colorectal cancer.
Not a fit: Patients who are not African American or those without a colorectal cancer diagnosis may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better understanding and treatment options for colorectal cancer in African American patients.
How similar studies have performed: Previous research has shown that understanding genetic and social factors can significantly impact cancer treatment outcomes, suggesting this approach has potential for success.
Where this research is happening
WASHINGTON, UNITED STATES
- GEORGETOWN UNIVERSITY — WASHINGTON, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: ROZEK, LAURA — GEORGETOWN UNIVERSITY
- Study coordinator: ROZEK, LAURA
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.